Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

Walsh, T J; Hiemenz, J W; Seibel, N L; Perfect, J R; Horwith, G; Lee, L; Silber, J L; DiNubile, M J; Reboli, A; Bow, E; Lister, J; Anaissie, E J

Walsh, T J; Hiemenz, J W; Seibel, N L; Perfect, J R; Horwith, G; Lee, L; Silber, J L; DiNubile, M J; Reboli, A; Bow, E; Lister, J; Anaissie, E J.

Affiliation

Walsh TJ; Infectious Diseases Section, National Cancer Institute, Bethesda, Maryland 20892, USA.

Clin Infect Dis ; 26(6): 1383-96, 1998 Jun.

Article in En | MEDLINE | ID: mdl-9636868

Subject(s)

Amphotericin B/therapeutic use; Antifungal Agents/therapeutic use; Mycoses/drug therapy; Phosphatidylcholines/therapeutic use; Phosphatidylglycerols/therapeutic use; Adult; Amphotericin B/adverse effects; Antifungal Agents/adverse effects; Aspergillosis/drug therapy; Candidiasis/drug therapy; Creatinine/blood; Cryptococcosis/drug therapy; Drug Combinations; Female; Humans; Male; Phosphatidylcholines/adverse effects; Phosphatidylglycerols/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phosphatidylcholines / Phosphatidylglycerols / Amphotericin B / Mycoses / Antifungal Agents Limits: Adult / Female / Humans / Male Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 1998 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links